{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:45:22Z","timestamp":1792028722157,"version":"4.4.0"},"reference-count":195,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuklearmedizin"],"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>This procedure guideline for SPECT examinations of striatal dopamine transporter availability is intended to support the planning, execution, quality control, interpretation and reporting of cerebral SPECT scans with [123I]ioflupane. It is an update and expansion built on the 2019 version of the procedure guideline. It was developed through an informal process as a consensus of the Neuroimaging Working Group of the German Society of Nuclear Medicine and in consultation with the German Neurological Society. It is intended for use by physicians and technical staff working in the field of nuclear medicine.<\/jats:p>","DOI":"10.1055\/a-2883-7728","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:42:25Z","timestamp":1785278545000},"source":"Crossref","is-referenced-by-count":1,"title":["S1-Handlungsempfehlung der Deutschen Gesellschaft f\u00fcr\u00a0Nuklearmedizin zur Durchf\u00fchrung von SPECT-Untersuchungen des Gehirns mit dem Dopamintransporter-Liganden [123I]Ioflupan (02\/2026)"],"prefix":"10.1055","author":[{"given":"Ralph","family":"Buchert","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Diagnostische und Interventionelle Radiologie und Nuklearmedizin, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie L.","family":"Albert","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Nuklearmedizin, Klinikum der LMU M\u00fcnchen, M\u00fcnchen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Barthel","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Nuklearmedizin, St\u00e4dtisches Klinikum Dessau, Dessau"},{"name":"Klinik und Poliklinik f\u00fcr Nuklearmedizin, Universit\u00e4t Leipzig, Leipzig"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Boecker","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Nuklearmedizin, Universit\u00e4tsklinikum Bonn, Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn, Bonn"},{"name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen (DZNE) Bonn-K\u00f6ln, Bonn, K\u00f6ln"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bouter","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Nuklearmedizin, Universit\u00e4tsmedizin G\u00f6ttingen, G\u00f6ttingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Nuklearmedizin, Klinikum der LMU M\u00fcnchen, M\u00fcnchen"},{"name":"Munich Cluster of Systems Neurology (SyNergy), Munich, Germany"},{"name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen (DZNE) M\u00fcnchen, M\u00fcnchen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Brumberg","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Nuklearmedizin, Universit\u00e4tsklinikum Freiburg, Fakult\u00e4t f\u00fcr Medizin, Albert-Ludwigs-Universit\u00e4t Freiburg, Freiburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Drzezga","sequence":"additional","affiliation":[{"name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen (DZNE) Bonn-K\u00f6ln, Bonn, K\u00f6ln"},{"name":"Klinik und Poliklinik f\u00fcr Nuklearmedizin, Uniklinik K\u00f6ln, K\u00f6ln"},{"name":"Institut f\u00fcr Neurowissenschaften und Medizin, Molekulare Organisation des Gehirns (INM-2), Forschungszentrum J\u00fclich, J\u00fclich"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Gr\u00fcnder","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Molekulares Neuroimaging, Zentralinstitut f\u00fcr Seelische Gesundheit, Medizinische Fakult\u00e4t Mannheim, Universit\u00e4t Heidelberg, Mannheim"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swen","family":"Hesse","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Nuklearmedizin, Universit\u00e4t Leipzig, Leipzig"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"la Foug\u00e8re","sequence":"additional","affiliation":[{"name":"Nuklearmedizin und Klinische Molekulare Bildgebung, Universit\u00e4tsklinikum T\u00fcbingen, T\u00fcbingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Lange","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Nuklearmedizin, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Lohmann","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Nuklearmedizin, Uniklinik RWTH Aachen, Aachen"},{"name":"Institut f\u00fcr Neurowissenschaften und Medizin, Abteilung Physik und Medizinische Bildgebung (INM-4), Forschungszentrum J\u00fclich, J\u00fclich"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Miederer","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Nuklearmedizin, Universit\u00e4tsmedizin der Johannes-Gutenberg-Universit\u00e4t Mainz, Mainz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Neumaier","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Neurowissenschaften und Medizin, Abteilung Nuklearchemie (INM-5), Forschungszentrum J\u00fclich, J\u00fclich"},{"name":"Institut f\u00fcr Radiochemie und Experimentelle Bildgebung, Uniklinik K\u00f6ln, K\u00f6ln"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Rominger","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik f\u00fcr Nuklearmedizin, Inselspital, Bern, Schweiz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Schreckenberger","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Nuklearmedizin, Universit\u00e4tsmedizin der Johannes-Gutenberg-Universit\u00e4t Mainz, Mainz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Yakushev","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Nuklearmedizin, TUM Klinikum Rechts der Isar, M\u00fcnchen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"van Eimeren","sequence":"additional","affiliation":[{"name":"Multimodale Neurobildgebung, Klinik f\u00fcr Nuklearmedizin & Klinik f\u00fcr Neurologie, Universit\u00e4t zu K\u00f6ln"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp T.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Nuklearmedizin, Universit\u00e4tsklinikum Freiburg, Fakult\u00e4t f\u00fcr Medizin, Albert-Ludwigs-Universit\u00e4t Freiburg, Freiburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Editor: Deutsche Gesellschaft f\u00fcr Nuklearmedizin e.V. [German Society of Nuclear Medicine]","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Other associations involved: German Neurological Society [Deutsche Gesellschaft f\u00fcr Neurologie e.V.]","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/a-0807-8137","article-title":"Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)","volume":"58","author":"K Tatsch","year":"2019","journal-title":"Nuklearmedizin"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00259-020-04817-8","article-title":"EANM practice guideline\/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0","volume":"47","author":"S Morbelli","year":"2020","journal-title":"Eur J Nucl Med Mol I"},{"issue":"02","key":"ref11","doi-asserted-by":"publisher","first-page":"II6","DOI":"10.1007\/BF03161076","article-title":"Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration","volume":"246","author":"D W Dickson","year":"1999","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","article-title":"Office of Rare Diseases neuropathologic criteria for corticobasal degeneration","volume":"61","author":"D W Dickson","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"issue":"08","key":"ref13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","article-title":"Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer\u2019s and Parkinson\u2019s diseases: rostrocaudal distribution","volume":"122","author":"M A Piggott","year":"1999","journal-title":"Brain"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/jnnp.58.2.160","article-title":"Clinicopathological study of 35 cases of multiple system atrophy","volume":"58","author":"G K Wenning","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.neuroimage.2005.03.034","article-title":"Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson\u2019s disease","volume":"26","author":"G Andringa","year":"2005","journal-title":"Neuroimage"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/mds.27316","article-title":"Nigrostriatal dopamine transporter availability in early Parkinson\u2019s disease","volume":"33","author":"P Fazio","year":"2018","journal-title":"Movement Disord"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1471-4159.1991.tb02580.x","article-title":"The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate-Nucleus","volume":"56","author":"H B Niznik","year":"1991","journal-title":"J Neurochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson\u2019s disease","volume":"47","author":"C S Lee","year":"2000","journal-title":"Ann Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/archneur.59.4.580","article-title":"Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease","volume":"59","author":"M J Ribeiro","year":"2002","journal-title":"Arch Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e209453","DOI":"10.1212\/WNL.0000000000209453","article-title":"Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism","volume":"102","author":"A Hastings","year":"2024","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3238\/arztebl.2019.0747","article-title":"Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes","volume":"116","author":"R Buchert","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2967\/jnumed.112.105379","article-title":"Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update","volume":"54","author":"K Tatsch","year":"2013","journal-title":"J Nucl Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ana.27223","article-title":"Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson\u2019s Disease","volume":"98","author":"V Dzialas","year":"2025","journal-title":"Ann Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s00115-013-3995-1","article-title":"[Differential diagnostics of Parkinson\u2019s disease with nuclear medicine procedures]","volume":"85","author":"P T Meyer","year":"2014","journal-title":"Nervenarzt"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/wco.0000000000000106","article-title":"Update on SPECT and PET in parkinsonism \u2013 part 1: imaging for differential diagnosis","volume":"27","author":"P T Meyer","year":"2014","journal-title":"Curr Opin Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"S353","DOI":"10.3233\/jpd-230385","article-title":"Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson\u2019s Disease","volume":"14","author":"H Theis","year":"2024","journal-title":"J Parkinsons Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1055\/a-1207-0515","article-title":"[Recommendation for the differentiated use of nuclear medical diagnostic for parkinsonian syndromes]","volume":"88","author":"T van Eimeren","year":"2020","journal-title":"Fortschr Neurol Psychiatr"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1007\/s00259-024-06803-w","article-title":"Neuroimaging biomarkers in the biological definition of Parkinson\u2019s disease and dementia with Lewy bodies \u2013 EANM position on current state, unmet needs and future perspectives","volume":"51","author":"M Brendel","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1007\/s00259-023-06154-y","article-title":"The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review","volume":"50","author":"M Jreige","year":"2023","journal-title":"Eur J Nucl Med Mol I"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00185-8","article-title":"Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis","volume":"7","author":"D Bega","year":"2021","journal-title":"Npj Parkinsons Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00702-021-02452-7","article-title":"Dopamine transporter (DAT) imaging in Parkinson\u2019s disease and related disorders","volume":"129","author":"T Brucke","year":"2022","journal-title":"J Neural Transm (Vienna)"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00415-024-12726-1","article-title":"Neuroanatomical and clinical correlates of prodromal dementia with Lewy bodies: a systematic literature review of neuroimaging findings","volume":"272","author":"D Conti","year":"2024","journal-title":"J\u00a0Neurol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-025-02921-3","article-title":"Neuroimaging in multiple system atrophy: clinical implications and novel developments","author":"W H Jost","year":"2025","journal-title":"J Neural Transm (Vienna)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2967\/jnumed.119.227140","article-title":"Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies","volume":"60","author":"V Kaasinen","year":"2019","journal-title":"J Nucl Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25103","article-title":"Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies","volume":"82","author":"V Kaasinen","year":"2017","journal-title":"Ann Neurol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3174\/ajnr.A8313","article-title":"Atypical Parkinsonian Syndromes: Structural, Functional, and Molecular Imaging Features","volume":"45","author":"G Keir","year":"2024","journal-title":"Am J Neuroradiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080872","article-title":"Molecular Imaging of the Dopamine Transporter","volume":"8","author":"G Palermo","year":"2019","journal-title":"Cells"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011234","article-title":"Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review","volume":"22","author":"G Palermo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e230133","DOI":"10.1148\/rg.230133","article-title":"Practical Overview of (123)I-Ioflupane Imaging in Parkinsonian Syndromes","volume":"44","author":"M K Mercer","year":"2024","journal-title":"Radiographics"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jnc.15561","article-title":"Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool","volume":"164","author":"N Nicastro","year":"2023","journal-title":"J Neurochem"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"372","DOI":"10.23736\/S1824-4785.17.03018-7","article-title":"Clinical utility and research frontiers of neuroimaging in movement disorders","volume":"61","author":"F Nobili","year":"2017","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1395413","DOI":"10.3389\/fneur.2024.1395413","article-title":"Practical use of DAT SPECT imaging in diagnosing dementia with Lewy bodies: a US perspective of current guidelines and future directions","volume":"15","author":"D M O\u2019Shea","year":"2024","journal-title":"Front Neurol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1590\/0004-282X-ANP-2022-S130","article-title":"Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson s disease: a narrative review","volume":"80","author":"R TV Otani","year":"2022","journal-title":"Arq Neuropsiquiatr"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/mdc3.14055","article-title":"I(123)-FP-CIT (DaTSCAN) SPECT beyond the Most Common Causes of Parkinsonism: A Systematic Review","volume":"11","author":"S Quintas","year":"2024","journal-title":"Mov Disord Clin Pract"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-022-00943-6","article-title":"Comparison of [18F]-FDOPA PET and [123I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome","volume":"12","author":"E Wallert","year":"2022","journal-title":"Ejnmmi Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"R B Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"S Gilman","year":"2008","journal-title":"Neurology"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy","volume":"37","author":"G K Wenning","year":"2022","journal-title":"Mov Disord"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"G U Hoglinger","year":"2017","journal-title":"Mov Disord"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"M J Armstrong","year":"2013","journal-title":"Neurology"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1002\/mds.10580","article-title":"Dopamine transporter imaging and SPECT in diagnostic workup of Parkinson\u2019s disease: A decision-analytic approach","volume":"18","author":"R C Dodel","year":"2003","journal-title":"Movement Disord"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00259-008-0777-2","article-title":"The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism","volume":"35","author":"K Van Laere","year":"2008","journal-title":"Eur J Nucl Med Mol I"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s002590000460","article-title":"The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism","volume":"28","author":"J Booij","year":"2001","journal-title":"European Journal of Nuclear Medicine"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/mds.20112","article-title":"Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes","volume":"19","author":"A M Catafau","year":"2004","journal-title":"Movement Disord"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/RLU.0000000000001696","article-title":"Utility of Follow-up Dopamine Transporter SPECT With 123I-FP-CIT in the Diagnostic Workup of Patients With Clinically Uncertain Parkinsonian Syndrome","volume":"42","author":"I Apostolova","year":"2017","journal-title":"Clin Nucl Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/mds.30255","article-title":"Normal [(18)F]FE-PE2I PET in Patients with Persistent Diagnostic Uncertainty after Abnormal [(123)I]FP-CIT SPECT","volume":"40","author":"M Dhadamus","year":"2025","journal-title":"Mov Disord"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/brain\/awaa365","article-title":"Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder","volume":"144","author":"D Arnaldi","year":"2021","journal-title":"Brain"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf191","article-title":"Pure autonomic failure: a natural history study of the Queen Square cohort","author":"G Chiaro","year":"2025","journal-title":"Brain"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1212\/WNL.0000000000207707","article-title":"DATScan in Mild Cognitive Impairment: Some Answers but More Questions","volume":"101","author":"F Ali","year":"2023","journal-title":"Neurology"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.1038\/s41467-024-51502-7","article-title":"Acetyl-DL-leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern-case reports","volume":"15","author":"W H Oertel","year":"2024","journal-title":"Nat Commun"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/mds.24000","article-title":"Dopamine Transporter Imaging in Autopsy-Confirmed Parkinson\u2019s Disease and Multiple System Atrophy","volume":"27","author":"L D Perju-Dumbrava","year":"2012","journal-title":"Movement Disord"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/00325481.2017.1282296","article-title":"Myths and misconceptions concerning contrast media-induced anaphylaxis: a narrative review","volume":"129","author":"I Bohm","year":"2017","journal-title":"Postgrad Med"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson\u2019s disease","volume":"34","author":"S Heinzel","year":"2019","journal-title":"Movement Disord"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson\u2019s disease","volume":"30","author":"D Berg","year":"2015","journal-title":"Movement Disord"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"I G McKeith","year":"2017","journal-title":"Neurology"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"I G McKeith","year":"2020","journal-title":"Neurology"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/syn.21838","article-title":"Characterization of [123I]FP-CIT binding to the dopamine transporter in the striatum of tree shrews by quantitative autoradiography","volume":"69","author":"S Geisler","year":"2015","journal-title":"Synapse"},{"key":"ref71","first-page":"1129","article-title":"SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT","volume":"37","author":"A Abi-Dargham","year":"1996","journal-title":"J Nucl Med"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1007\/s002590050170","article-title":"Human biodistribution and dosimetry of iodine-123-fluoroalkyl analogs of beta-CIT","volume":"24","author":"A Abi-Dargham","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s002590050190","article-title":"Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters","volume":"25","author":"J Booij","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.apradiso.2013.09.006","article-title":"Determination of the biodistribution and dosimetry of (1)(2)(3)I-FP-CIT in male patients with suspected Parkinsonism or Lewy body dementia using planar and combined planar and SPECT\/CT imaging","volume":"82","author":"M Sydoff","year":"2013","journal-title":"Appl Radiat Isot"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2967\/jnumed.114.138032","article-title":"Safety analysis of 10 clinical trials and for 13 years after first approval of ioflupane 123I injection (DaTscan)","volume":"55","author":"D G Grosset","year":"2014","journal-title":"J Nucl Med"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.2967\/jnumed.108.057026","article-title":"The Presence of Ethanol in Radiopharmaceutical Injections","volume":"49","author":"K Serdons","year":"2008","journal-title":"Journal of Nuclear Medicine"},{"key":"ref78","first-page":"A1458","article-title":"Strahlenexposition bei Flugreisen","volume":"93","author":"D Schalch","year":"1996","journal-title":"Deutsches \u00c4rzteblatt"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00259-007-0621-0","article-title":"Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs","volume":"35","author":"J Booij","year":"2008","journal-title":"Eur J Nucl Med Mol I"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1007\/s00259-023-06171-x","article-title":"A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice","volume":"50","author":"Y Chahid","year":"2023","journal-title":"Eur J Nucl Med Mol I"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00259-024-06989-z","article-title":"Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion","volume":"52","author":"I Apostolova","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000540105","article-title":"The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes","volume":"24","author":"I H Kang","year":"2024","journal-title":"Neurodegener Dis"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000491524","article-title":"Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review","volume":"87","author":"G A Fava","year":"2018","journal-title":"Psychother Psychosom"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.drugalcdep.2011.03.011","article-title":"Decreased striatal dopamine transporters in codeine-containing cough syrup abusers","volume":"118","author":"H F Hou","year":"2011","journal-title":"Drug Alcohol Depen"},{"key":"ref85","first-page":"359","article-title":"Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects","volume":"48","author":"J Booij","year":"2007","journal-title":"J Nucl Med"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamapsychiatry.2017.0135","article-title":"Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine A Systematic Review and Meta-analysis","volume":"74","author":"A H Ashok","year":"2017","journal-title":"Jama Psychiat"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/Mnm.0000000000001785","article-title":"Should we reconsider blocking the thyroid for 123I-Ioflupane studies in elderly patients: quantifying radiation dose to the unblocked thyroid and implications for clinical practice","volume":"45","author":"D WA Morton","year":"2024","journal-title":"Nucl Med Commun"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s00259-010-1726-4","article-title":"Thyroid protection before 123I-ioflupane (DaTSCAN) imaging","volume":"38","author":"Y Mouraeff","year":"2011","journal-title":"Eur J Nucl Med Mol I"},{"key":"ref91","first-page":"533","article-title":"Effect of Perchlorate on the Human Thyroid Gland","volume":"1","author":"J B Stanbury","year":"1952","journal-title":"Metabolism"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0031-6997(24)01350-4","article-title":"Perchlorate and the thyroid gland","volume":"50","author":"J Wolff","year":"1998","journal-title":"Pharmacol Rev"},{"key":"ref93","first-page":"753","article-title":"One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson\u2019s disease by [123I]FPCIT SPECT","volume":"40","author":"J Booij","year":"1999","journal-title":"J Nucl Med"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fmed.2020.00235","article-title":"Faster Acquisition for Dopamine Transporter Imaging Using Swiftscan Step and Shoot Continuous SPECT Without Impairing Visual and Semiquantitative Analysis","author":"M Bailly","year":"2020","journal-title":"Front Med-Lausanne"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/RLU.0000000000003969","article-title":"Prospective Paired Comparison of 123I-FP-CIT SPECT Images Obtained With a 360 degrees -CZT and a Conventional Camera","volume":"47","author":"Y Piatkova","year":"2022","journal-title":"Clin Nucl Med"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13550-018-0436-y","article-title":"Clinical evaluation of [(123)I]FP-CIT SPECT scans on the novel brain-dedicated InSPira HD SPECT system: a head-to-head comparison","volume":"8","author":"S M Adriaanse","year":"2018","journal-title":"Ejnmmi Res"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"446","DOI":"10.2967\/jnumed.123.266276","article-title":"Dopamine Transporter SPECT with 12-Minute Scan Duration Using Multiple-Pinhole Collimators","volume":"65","author":"R Buchert","year":"2024","journal-title":"J Nucl Med"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"225002","DOI":"10.1088\/1361-6560\/aae76c","article-title":"Optimized image acquisition for dopamine transporter imaging with ultra-high resolution clinical pinhole SPECT","volume":"63","author":"Y Chen","year":"2018","journal-title":"Phys Med Biol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40658-025-00795-8","article-title":"Comparison of SZ-HRX and LEHR collimators for reduced-duration 123I-ioflupane brain SPECT\/CT: a phantom study","volume":"12","author":"M Pavoine","year":"2025","journal-title":"EJNMMI Phys"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12149-013-0789-2","article-title":"Radius dependence of FP-CIT quantification: a Monte Carlo-based simulation study","volume":"28","author":"W Koch","year":"2014","journal-title":"Ann Nucl Med"},{"key":"ref102","first-page":"822","article-title":"Spect Resolution and Uniformity Improvements by Non-Circular Orbit","volume":"24","author":"S C Gottschalk","year":"1983","journal-title":"Journal of Nuclear Medicine"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/RLU.0b013e318251e1b3","article-title":"Image quality and data quantification in dopamine transporter SPECT: advantage of 3-dimensional OSEM reconstruction?","volume":"37","author":"O H Winz","year":"2012","journal-title":"Clin Nucl Med"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00259-009-1212-z","article-title":"The impact of reconstruction method on the quantification of DaTSCAN images","volume":"37","author":"J C Dickson","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/j.zemedi.2025.10.006","article-title":"Delayed convergence of iterative reconstruction in dopamine transporter SPECT with multiple-pinhole collimators","author":"L Jedid","year":"2025","journal-title":"Z Med Phys"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1007\/s00259-023-06293-2","article-title":"No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome","volume":"50","author":"T Schiebler","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"e8484","DOI":"10.1097\/MD.0000000000008484","article-title":"Attenuation and scatter correction in I-123 FP-CIT SPECT do not affect the clinical diagnosis of dopaminergic system neurodegeneration","volume":"96","author":"M Akahoshi","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/a-2566-1487","article-title":"The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023","volume":"64","author":"R Buchert","year":"2025","journal-title":"Nuklearmedizin"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"e108328","DOI":"10.1371\/journal.pone.0108328","article-title":"CT-based attenuation correction in I-123-ioflupane SPECT","volume":"9","author":"C Lange","year":"2014","journal-title":"PLoS One"},{"key":"ref110","first-page":"278","article-title":"Influence of CT-based attenuation correction on dopamine transporter SPECT with [(123)I]FP-CIT","volume":"5","author":"C Lapa","year":"2015","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1109\/Tns.1978.4329385","article-title":"Method for Attenuation Correction in Radionuclide Computed Tomography","volume":"25","author":"L T Chang","year":"1978","journal-title":"Ieee T Nucl Sci"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s00330-015-3667-6","article-title":"Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy","volume":"25","author":"C Lange","year":"2015","journal-title":"Eur Radiol"},{"key":"ref113","first-page":"2216","article-title":"Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT","volume":"34","author":"T Ichihara","year":"1993","journal-title":"J Nucl Med"},{"key":"ref114","first-page":"181","article-title":"Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT","volume":"39","author":"H Iida","year":"1998","journal-title":"J Nucl Med"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2967\/jnmt.112.117184","article-title":"The Semicolon Sign: Dopamine Transporter Imaging Artifact from Head Tilt","volume":"41","author":"M F Covington","year":"2013","journal-title":"Journal of Nuclear Medicine Technology"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2967\/jnmt.120.258491","article-title":"Pitfalls and Artifacts of 123I-Ioflupane SPECT in Parkinsonian Syndromes: A Quality Improvement Teaching Tool","volume":"49","author":"C AT Santos","year":"2021","journal-title":"Journal of Nuclear Medicine Technology"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-017-0175-6","article-title":"[123I] FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods","volume":"4","author":"L Tossici-Bolt","year":"2017","journal-title":"Ejnmmi Physics"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.3390\/tomography10100119","article-title":"Optimal DaTQUANT Thresholds for Diagnostic Accuracy of Dementia with Lewy Bodies (DLB) and Parkinson\u2019s Disease (PD)","volume":"10","author":"P H Kuo","year":"2024","journal-title":"Tomography"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s00259-022-06069-0","article-title":"Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson\u2019s Disease (PD) and dementia with Lewy bodies (DLB)","volume":"50","author":"F Lanfranchi","year":"2023","journal-title":"Eur J Nucl Med Mol I"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3413\/Nukmed-0659-14-04","article-title":"Global scaling for semi-quantitative analysis in FP-CIT SPECT","volume":"53","author":"D Kupitz","year":"2014","journal-title":"Nuklearmedizin"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00259-012-2304-8","article-title":"Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database","volume":"40","author":"F Nobili","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-020-00304-z","article-title":"Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT","volume":"7","author":"H Schmitz-Steinkr\u00fcger","year":"2020","journal-title":"Ejnmmi Physics"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13550-023-00983-6","article-title":"Semi-quantitative analysis of visually normal (123)I-FP-CIT across three large databases revealed no difference between control and patients","volume":"13","author":"A Flaus","year":"2023","journal-title":"Ejnmmi Res"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"102807","DOI":"10.1016\/j.nicl.2021.102807","article-title":"Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials","volume":"32","author":"E A Honkanen","year":"2021","journal-title":"Neuroimage Clin"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13550-019-0506-9","article-title":"Diagnostic performance of the specific uptake size index for semi-quantitative analysis of I-123-FP-CIT SPECT: harmonized multi-center research setting versus typical clinical single-camera setting","volume":"9","author":"R Buchert","year":"2019","journal-title":"Ejnmmi Res"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"N227","DOI":"10.1088\/0031-9155\/49\/14\/n03","article-title":"The specific uptake size index for quantifying radiopharmaceutical uptake","volume":"49","author":"J S Fleming","year":"2004","journal-title":"Phys Med Biol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/MNM.0b013e32829152c9","article-title":"Validation of a resolution-independent method for the quantification of 123I-FP-CIT SPECT scans","volume":"28","author":"I Goethals","year":"2007","journal-title":"Nucl Med Commun"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","article-title":"Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio","volume":"33","author":"L Tossici-Bolt","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmp.2020.05.010","article-title":"MRI-guided voxel-based automatic semi-quantification of dopamine transporter imaging","volume":"75","author":"J Trnka","year":"2020","journal-title":"Phys Med"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s10072-018-3437-8","article-title":"Semi-quantitative dopamine transporter standardized uptake value in comparison with conventional specific binding ratio in [123I] FP-CIT single-photon emission computed tomography (DaTscan)","volume":"39","author":"Y Wakabayashi","year":"2018","journal-title":"Neurol Sci"},{"key":"ref131","first-page":"S216","article-title":"ENCDAT-European Database of I-123-FP-CIT SPECT Scans of Healthy Controls: First Results","volume":"36","author":"K Tatsch","year":"2009","journal-title":"Eur J Nucl Med Mol I"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/acn3.644","article-title":"The Parkinson\u2019s progression markers initiative (PPMI) \u2013 establishing a PD biomarker cohort","volume":"5","author":"K Marek","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13550-020-00727-w","article-title":"Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools","volume":"10","author":"S Morbelli","year":"2020","journal-title":"Ejnmmi Res"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.2967\/jnumed.116.189266","article-title":"Diagnostic Performance of the Visual Reading of (123)I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia","volume":"58","author":"J Booij","year":"2017","journal-title":"J Nucl Med"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10072-017-2936-3","article-title":"Combined visual and semi-quantitative assessment of (123)I-FP-CIT SPECT for the diagnosis of dopaminergic neurodegenerative diseases","volume":"38","author":"J Ueda","year":"2017","journal-title":"Neurol Sci"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/RLU.0000000000002333","article-title":"Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT\/CT Imaging","volume":"44","author":"R A Werner","year":"2019","journal-title":"Clin Nucl Med"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/MNM.0000000000001968","article-title":"Comparison of visual interpretation of [I-123] FP-CIT SPECT scans versus reference-based quantitative analysis utilizing a Japanese normal database","volume":"46","author":"R Yamakuni","year":"2025","journal-title":"Nucl Med Commun"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11307-015-0889-6","article-title":"Establishing On-Site Reference Values for (123)I-FP-CIT SPECT (DaTSCAN(R)) Using a Cohort of Individuals with Non-Degenerative Conditions","volume":"18","author":"N Nicastro","year":"2016","journal-title":"Mol Imaging Biol"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/mds.28019","article-title":"Lack of Asymmetry of Nigrostriatal Dopaminergic Function in Healthy Subjects","volume":"35","author":"A Garrido","year":"2020","journal-title":"Mov Disord"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease","volume":"136","author":"J H Kordower","year":"2013","journal-title":"Brain"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s00259-018-4031-2","article-title":"Clinical utility of FDG PET in Parkinson\u2019s disease and atypical parkinsonism associated with dementia","volume":"45","author":"Z Walker","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","article-title":"(18)F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment","volume":"58","author":"P T Meyer","year":"2017","journal-title":"J Nucl Med"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00259-015-3191-6","article-title":"Different loss of dopamine transporter according to subtype of multiple system atrophy","volume":"43","author":"H W Kim","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112893","article-title":"Follow-Up Findings in Multiple System Atrophy from [(123)I]Ioflupane Single-Photon Emission Computed Tomography (SPECT): A Prospective Study","volume":"11","author":"J Villena-Salinas","year":"2023","journal-title":"Biomedicines"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1001\/archneur.61.6.919","article-title":"Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies","volume":"61","author":"J T O\u2019Brien","year":"2004","journal-title":"Arch Neurol"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324606","article-title":"(123)I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson\u2019s disease and Alzheimer\u2019s disease: a new quantitative analysis of autopsy confirmed cases","author":"F PM Oliveira","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1212\/WNL.0000000000003512","article-title":"Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB","volume":"88","author":"A J Thomas","year":"2017","journal-title":"Neurology"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s00259-016-3323-7","article-title":"Is dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies?","volume":"43","author":"F Nobili","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s00259-016-3312-x","article-title":"[(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies","volume":"43","author":"J J van der Zande","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2020.12.009","article-title":"The value of multimodal imaging with (123)I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer\u2019s disease dementia","volume":"99","author":"T Miyagawa","year":"2021","journal-title":"Neurobiol Aging"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"102062","DOI":"10.1016\/j.nicl.2019.102062","article-title":"Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer\u2019s disease pathology: An (123)I-FP-CIT SPECT study","volume":"25","author":"J J van der Zande","year":"2020","journal-title":"Neuroimage Clin"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1097\/RLU.0000000000000554","article-title":"Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer\u2019s dementia","volume":"40","author":"T S Spehl","year":"2015","journal-title":"Clin Nucl Med"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"fcaf284","DOI":"10.1093\/braincomms\/fcaf284","article-title":"Striatal dopaminergic patterns and clinical features in frontotemporal dementia","volume":"7","author":"D Urso","year":"2025","journal-title":"Brain Commun"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pscychresns.2016.10.007","article-title":"Test-retest reproducibility of extrastriatal binding with (123)I-FP-CIT SPECT in healthy male subjects","volume":"258","author":"K Matsuoka","year":"2016","journal-title":"Psychiatry Res Neuroimaging"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/BF02984583","article-title":"Reproducibility of dopamine transporter density measured with 123I-FPCIT SPECT in normal control and Parkinson\u2019s disease patients","volume":"18","author":"T Tsuchida","year":"2004","journal-title":"Ann Nucl Med"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"20200118","DOI":"10.1259\/bjrcr.20200118","article-title":"Substantia nigra micro-haemorrhage causing ipsilateral unilateral Parkinsonism and abnormal dopamine transporter scan uptake","volume":"7","author":"A Ghoneim","year":"2021","journal-title":"BJR Case Rep"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00234-024-03506-9","article-title":"The eagle-wing finding in FP-CIT SPECT, as a characteristic finding in patients with DESH- type iNPH","volume":"67","author":"K Miyazaki","year":"2025","journal-title":"Neuroradiology"},{"key":"ref158","first-page":"293","article-title":"The neuropathologic diagnosis of secondary parkinsonian syndromes","volume":"69","author":"K A Jellinger","year":"1996","journal-title":"Adv Neurol"},{"key":"ref159","first-page":"1694","article-title":"Loss of dopamine transporter binding in Parkinson\u2019s disease follows a single exponential rather than linear decline","volume":"45","author":"J Schwarz","year":"2004","journal-title":"J Nucl Med"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/mds.27361","article-title":"Longitudinal Change of Clinical and Biological Measures in Early Parkinson\u2019s Disease: Parkinson\u2019s Progression Markers Initiative Cohort","volume":"33","author":"T Simuni","year":"2018","journal-title":"Mov Disord"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1093\/brain\/aws253","article-title":"Left hemispheric predominance of nigrostriatal dysfunction in Parkinson\u2019s disease","volume":"135","author":"C Scherfler","year":"2012","journal-title":"Brain"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s00415-021-10809-x","article-title":"Unexpected (123I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT","volume":"269","author":"B Roberta","year":"2022","journal-title":"Journal of Neurology"},{"key":"ref163","first-page":"S420","article-title":"Patients with rest-tremor and scans with ipsilateral dopaminergic deficit: (SWIDD)","volume":"27","author":"M Stamelou","year":"2012","journal-title":"Movement Disord"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00259-020-05085-2","article-title":"Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT","volume":"48","author":"H Schmitz-Steinkruger","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00259-015-3304-2","article-title":"Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes","volume":"43","author":"N L Albert","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12149-019-01352-x","article-title":"(123)I-FP-CIT striatal binding ratios do not decrease significantly with age in older adults","volume":"33","author":"G Roberts","year":"2019","journal-title":"Ann Nucl Med"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.parkreldis.2020.06.019","article-title":"DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson\u2019s disease: Longitudinal data from the PPMI study","volume":"77","author":"C Koros","year":"2020","journal-title":"Parkinsonism Relat D"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/MNM.0000000000001514","article-title":"VNTR polymorphism in the SLC6A3 gene does not influence dopamine transporter availability measured by [18F]FE-PE2I PET or [123I]FP-Cit SPECT","volume":"43","author":"Mo S Jakobson","year":"2022","journal-title":"Nucl Med Commun"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s12149-021-01657-w","article-title":"No effect of Parkinson\u2019s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjects","volume":"35","author":"K Pak","year":"2021","journal-title":"Ann Nucl Med"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jns.2018.10.001","article-title":"[(123)I]Ioflupane imaging in Caucasians and non-Caucasians: Are there any differences?","volume":"395","author":"A Ahmed","year":"2018","journal-title":"J\u00a0Neurol Sci"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2967\/jnmt.123.265806","article-title":"Differences in [(123)I]Ioflupane Striatal Binding Between African American and White Patients","volume":"52","author":"J Huang","year":"2024","journal-title":"J Nucl Med Technol"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2967\/jnmt.119.231423","article-title":"Accuracy of Dopamine Transporter Imaging with (123)I-Ioflupane in Hispanic and Non-Hispanic Patients","volume":"48","author":"T F Lundeen","year":"2020","journal-title":"J Nucl Med Technol"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"105844","DOI":"10.1016\/j.parkreldis.2023.105844","article-title":"Educational level and its association with dopamine transporter loss in patients with Parkinson\u2019s disease","volume":"115","author":"M C Hoenig","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1038\/s41380-024-02581-x","article-title":"Chronic social stressors and striatal dopamine functioning in humans: A systematic review of SPECT and PET studies","volume":"29","author":"R Schalbroeck","year":"2024","journal-title":"Mol Psychiatry"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/08919887241281062","article-title":"Socioenvironmental Factors are Associated With Dopamine Transporter Availability in Healthy Individuals but not in Parkinson\u2019s Disease","volume":"38","author":"S Cayir","year":"2025","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1038\/s41598-018-22814-8","article-title":"The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters","volume":"8","author":"S B Nam","year":"2018","journal-title":"Sci Rep"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuroimage.2012.09.011","article-title":"No association between striatal dopamine transporter binding and body mass index: A multi-center European study in healthy volunteers","volume":"64","author":"E van de Giessen","year":"2013","journal-title":"Neuroimage"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11111428","article-title":"Striatal Dopamine Transporter Availability Is Not Associated with Food Craving in Lean and Obese Humans; a Molecular Imaging Study","volume":"11","author":"J van Son","year":"2021","journal-title":"Brain Sci"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/mds.29597","article-title":"Dopamine Transporter Availability in Early Parkinson\u2019s Disease is Dependent on Sunlight Exposure","volume":"38","author":"J Booij","year":"2023","journal-title":"Movement Disord"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.1186\/2191-219x-3-39","article-title":"No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT","volume":"3","author":"G Thomsen","year":"2013","journal-title":"Ejnmmi Res"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.pnpbp.2007.08.018","article-title":"Decreased dopamine transporter availability in male smokers \u2013 a dual isotope SPECT study","volume":"32","author":"Y K Yang","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00702-018-1863-7","article-title":"Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective (123)I-FP-CIT SPECT imaging genetic study","volume":"125","author":"S Hellwig","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1055\/a-2784-7591","article-title":"Difficult-to-interpret dopamine transporter SPECT with [123I]ioflupane in the diagnosis of parkinsonism","volume":"65","author":"I Apostolova","year":"2026","journal-title":"Nuklearmedizin"},{"key":"ref184","first-page":"301","article-title":"Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images","volume":"55","author":"P T Meyer","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13550-022-00923-w","article-title":"Multiple-pinhole collimators improve intra- and between-rater agreement and the certainty of the visual interpretation in dopamine transporter SPECT","volume":"12","author":"F Mathies","year":"2022","journal-title":"Ejnmmi Res"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/s-0034-1398585","article-title":"Dopamintransporter-SPECT mit [123I] FP-CIT: Empfehlungen f\u00fcr die visuelle Beurteilung","volume":"38","author":"R Buchert","year":"2015","journal-title":"Der Nuklearmediziner"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1177\/1877718X251315651","article-title":"A perspective of persons with Parkinson\u2019s disease on the contribution of alpha-synuclein seed amplification assay biomarker to the diagnosis of Parkinson\u2019s disease","volume":"15","author":"S Bowen","year":"2025","journal-title":"J Parkinsons Dis"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.parkreldis.2021.04.007","article-title":"Consistent skin alpha-synuclein positivity in REM sleep behavior disorder \u2013 A two center two-to-four-year follow-up study","volume":"86","author":"K Doppler","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1007\/s00415-023-11810-2","article-title":"Seed amplification assay results illustrate discrepancy in Parkinson\u2019s disease clinical diagnostic accuracy and error rates","volume":"270","author":"J S Middleton","year":"2023","journal-title":"J Neurol"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"107083","DOI":"10.1016\/j.parkreldis.2024.107083","article-title":"Convention vs. Innovation II: Convention vs. Innovation II: Skin biopsy for synuclein inclusions will replace dopamine transporter imaging for Parkinson disease diagnosis","volume":"126","author":"L S Rosenthal","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"G U Hoglinger","year":"2024","journal-title":"Lancet Neurol"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1007\/s00259-025-07188-0","article-title":"Feasibility of a single-day protocol for SPECT and PET assessment of dopamine transporter availability, cardiac innervation and metabolic patterns in patients with movement disorders","volume":"52","author":"M Scheifele","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research","volume":"23","author":"T Simuni","year":"2024","journal-title":"Lancet Neurol"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41408-022-00629-1","article-title":"Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies","volume":"12","author":"A D Cohen","year":"2022","journal-title":"Blood Cancer J"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/Rlu.0000000000005700","article-title":"Detection of the Cingulate Island Sign by Early Perfusion Imaging in Dopamine Transporter SPECT With Multiple-Pinhole Collimators","volume":"50","author":"A Karimzadeh","year":"2025","journal-title":"Clinical Nuclear Medicine"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/RLU.0000000000005764","article-title":"Early Perfusion [123 I]FP-CIT SPECT Imaging With a 360-degree CZT Camera in Dementia With Lewy Bodies","volume":"50","author":"A Verger","year":"2025","journal-title":"Clin Nucl Med"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s12149-014-0878-x","article-title":"Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson\u2019s disease and Atypical Parkinsonian syndromes using DaTSCAN(R) SPECT","volume":"28","author":"A Davidsson","year":"2014","journal-title":"Ann Nucl Med"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ane.13653","article-title":"Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes","volume":"146","author":"Q S Chen","year":"2022","journal-title":"Acta Neurol Scand"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mds.23380","article-title":"Residual striatal dopaminergic nerve terminals in very long-standing Parkinson\u2019s disease: a single photon emission computed tomography imaging study","volume":"26","author":"R Djaldetti","year":"2011","journal-title":"Mov Disord"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/mds.28818","article-title":"Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson\u2019s Disease Patients with GBA Mutations","volume":"37","author":"S P Caminiti","year":"2022","journal-title":"Movement Disord"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3233\/Jpd-212761","article-title":"Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson\u2019s Disease Subtypes","volume":"11","author":"K Knudsen","year":"2021","journal-title":"J Parkinson Dis"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00685-3","article-title":"Investigating the aspect of asymmetry in brain-first versus body-first Parkinson\u2019s disease","volume":"10","author":"S S Loevdal","year":"2024","journal-title":"Npj Parkinsons Dis"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1007\/s00259-024-06748-0","article-title":"CYP3A4 inhibitors may influence the quantification of [(123)I]I-FP-CIT SPECT scans","volume":"51","author":"J Booij","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref204","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ac2470","article-title":"Convolutional neural network based attenuation correction for(123)I-FP-CIT SPECT with focused striatum imaging","volume":"66","author":"Y Chen","year":"2021","journal-title":"Phys Med Biol"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"e17976","DOI":"10.1002\/mp.17976","article-title":"Development and in silico imaging trial evaluation of a deep-learning-based transmission-less attenuation compensation method for DaT SPECT","volume":"52","author":"Z Yu","year":"2025","journal-title":"Med Phys"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12149-025-02038-3","article-title":"Fully automatic categorical analysis of striatal subregions in dopamine transporter SPECT using a convolutional neural network","volume":"39","author":"T Buddenkotte","year":"2025","journal-title":"Ann Nucl Med"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00259-023-06566-w","article-title":"Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptance","volume":"51","author":"T Budenkotte","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref208","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1007\/s00259-019-04502-5","article-title":"Automatic classification of dopamine transporter SPECT: deep convolutional neural networks can be trained to be robust with respect to variable image characteristics","volume":"46","author":"M Wenzel","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.nicl.2017.09.010","article-title":"Refining diagnosis of Parkinson\u2019s disease with deep learning-based interpretation of dopamine transporter imaging","volume":"16","author":"H Choi","year":"2017","journal-title":"Neuroimage-Clin"},{"key":"ref210","doi-asserted-by":"publisher","DOI":"10.1055\/a-2890-8325","article-title":"On the utility of ChatGPT in conducting a literature review on deep learning for dopamine transporter SPECT with [(1)(2)(3)I]ioflupane","author":"T Buddenkotte","year":"2026","journal-title":"Nuklearmedizin"}],"container-title":["Nuklearmedizin - NuclearMedicine"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2883-7728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:42:29Z","timestamp":1785278549000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2883-7728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":195,"URL":"https:\/\/doi.org\/10.1055\/a-2883-7728","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0029-5566","2567-6407"],"issn-type":[{"value":"0029-5566","type":"print"},{"value":"2567-6407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}